City of Hope is an independent biomedical research, treatment and education institution that specializes in providing the treatment of cancer, diabetes, AIDS and other life-threatening diseases. Founded in 1913, it performs laparoscopic prostate surgeries, bone marrow and stem cell transplants and hundreds of clinical studies. City of Hope s research has led to the breakthrough of various cancer drugs, such as Herceptin, Rituxan, Avastin and Erbitux, as well as synthetic human insulin. It is a founding member of the National Comprehensive Cancer Network, which defines and sets standards for cancer care nationally. City of Hope offers hands-on fellowships and residencies in several areas, including cancer genetics, developmental biology, urology, surgical oncology and molecular epidemiology. It maintains an office in Bellevue, Wash.